UCI statement on Samuel Sánchez Gonzalez
The Union Cycliste Internationale (UCI) announces that Spanish rider Samuel Sánchez Gonzalez was notified of an Adverse Analytical Finding (AAF) of GHRP-2* in a sample collected in the scope of out-of-competition control on 9 August 2017.
The doping control was planned and carried out by the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the UCI, in charge of defining and implementing the anti-doping strategy in cycling.
The rider has the right to request and attend the analysis of the B sample.
In accordance with UCI Anti-Doping Rules, the rider has been provisionally suspended until the adjudication of the affair.
At this stage of the procedure, the UCI will not comment any further on any of these matters.
(*) GH-Releasing Peptides (GHRPs) are classified as “Peptide Hormones, Growth Factors, Related Substances and Mimetics” as per the World Anti-Doping Prohibited List 2017.